Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Slides:

Advertisements

Similar presentations

Medical Management for BPH: The Role of Combination Therapy

Advertisements

Pascal Rischmann European Urology Supplements

Volume 64, Issue 3, Pages (September 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 63, Issue 5, Pages (May 2013)

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections Rodolfo Montironi,

Management of Acute and Chronic Retention in Men

Volume 66, Issue 6, Pages (December 2014)

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Bladder Cancer: Management and Future Directions

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Volume 63, Issue 1, Pages (January 2013)

Martin C. Michel European Urology Supplements

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

Bladder Cancer: A Major Public Health Issue

What is New in Bladder Cancer Diagnosis and Management?

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Back to the Future: Introduction and Conclusions

What is New in Hormone Therapy for Prostate Cancer in 2007?

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

Volume 64, Issue 3, Pages (September 2013)

Counselling the Prostate Cancer Patient

Laurent Boccon-Gibod European Urology Supplements

Human Papilloma Virus, Histopathological, and Molecular Subtyping in Penile Cancer: Relevance for Prognosis and Therapy Kerstin Junker, Sebastian Hölters,

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

An Update of Current Practice in Hypospadias Surgery

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Richard C. Harkaway European Urology Supplements

The Economic Costs of Overactive Bladder in Germany

Volume 50, Issue 5, Pages (November 2006)

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

Ian Milsom European Urology Supplements

The Importance of Testosterone Control in Prostate Cancer

Optimal Testosterone Control and Eligard®

Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice Claus Roehrborn European Urology.

Neal Shore European Urology Supplements

Impact of Tamsulosin OCAS on Energy of Patients with LUTS/BPH

Long-Term Hormonal Therapy: Who Would Benefit?

Bladder Cancer: Highlights from 2006

Sergio Bracarda European Urology Supplements

Christian Stief European Urology Supplements

New Trends in Managing the Prostate Cancer Patient

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Ureteropelvic Junction Obstruction

Emmanuel Chartier-Kastler, Kate Davidson European Urology Supplements

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Who Forms Stones and Why?

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia? Vincenzo Mirone

The European Online Sexual Survey (EOSS): Pan-European Perspectives on the Impact of Premature Ejaculation and Treatment-Seeking Behavior John Dean

Improving Flexibility and Quality of Life for Your Patients: A Must?

Profile of Silodosin European Urology Supplements

Robotic Cystectomy Versus Open Cystectomy: Are We There Yet?

Volume 52, Issue 4, Pages (October 2007)

New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men

Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis

The Increasing Responsibility of the Urologist in Maintaining Bone Health in Prostate Cancer Patients Kurt Miller European Urology Supplements Volume.

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Beyond Skeletal-Related Events

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Counselling of the Prostate Cancer Patient as a Whole Person

Joaquim Bellmunt European Urology Supplements

Classification of Mixed Incontinence

The Impact of Premature Ejaculation on Partners and Relationships

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Emmanuel Chartier-Kastler, Andrea Tubaro European Urology Supplements

Diagnosis and Management of Cryptorchidism

New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer Noel W. Clarke European Urology Supplements

Jan Roigas European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

Presentation transcript:

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology Supplements Volume 8, Issue 5, Pages 458-463 (April 2009) DOI: 10.1016/j.eursup.2008.12.003 Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 1 Relationship between number of patients and results. European Urology Supplements 2009 8, 458-463DOI: (10.1016/j.eursup.2008.12.003) Copyright © 2009 European Association of Urology Terms and Conditions